Archer Materials Limited · ASX:AXE
Archer Materials — Investor Presentation (December 2019)
35 slides from Archer Materials's investor presentation, December 2019

Slide 1: Corporate Presentation
/ Corporate Presentation Excellence in materials technology. 1

Slide 2: Disclaimer
/ Disclaimer The material contained in this document is a presentation of general information about the activities of Archer and its related bodies corporate (together the “Archer Group”), current as at the date of this presentation. It is provided in summary and does not purport to be complete. You

Slide 3: Company Snapshot
/ Company Snapshot Archer Materials Limited ASX: AXE 3

Slide 4: Board and Executive Management
/ Board and Executive Management 4

Slide 5: Capital Structure & Overview
/ Capital Structure & Overview $1.4m 197.1m Cash at bank as of 30 Sept 2019 Number of ordinary shares on issue $0.13 $25.6m Share price (24 Oct 2019) Market capitalisation (24 Oct 2019) 28% Of issued shares held by top 20 8% Of issued shares held by Archer’s shareholders Board and Executive Manageme

Slide 6: Archer provides shareholders exposure to innovative technologies and the materials that underpin them
Archer provides shareholders exposure to financial returns from innovative technologies and the materials that underpin them Our strategy is to build an industry-leading Materials Technology company, that delivers maximum value to our shareholders through the commercialisation of assets at various s

Slide 7: Advanced Materials
/ Advanced Materials Materials are the tangible basis of all technology. 7

Slide 8: The acquisition of Carbon Allotropes enabled Archer to expand its market position
The acquisition of Carbon Allotropes enabled Archer to expand its market position Archer’s growth involves contributing to complex global challenges. Archer is uniquely positioning to meet global markets’ needs through a number of key strengths: + Strong, globally filed patents protecting credible,

Slide 9: Significant Developments in 2018-2019
/ Significant Developments in 2018-2019 Quantum Human Reliable Technology Health Energy + Archer obtains exclusive licence to + High quality graphene inks + Collaboration & access quantum technology IP (QTIP) prepared and tested for printed agreements to build & test Li-ion biosensing technologies b

Slide 10: 12CQ: Building a world-first qubit processor chip
/ Quantum Technology 12CQ Building a world-first qubit processor chip 10

Slide 11: Successful commercialisation of 12CQ chip could catalyse a global multibillion dollar industry
Successful commercialisation of Archer’s 12CQ chip technology could catalyse a global multibillion dollar industry $30b $715b 70% Forecast size of Global semiconductor Of semiconductor quantum computing industry revenue2 manufacturing located industry in 20221 in Asia2 50% $4b 88% Australians now ow

Slide 12: Successful development of 12CQ chip could enable widespread ownership of quantum computing
Archer staff operating quantum device fabrication instruments at the Research and Prototype Foundry. Successful development of Archer’s 12CQ chip could enable widespread ownership of quantum computing powered technology 1 World-record room-temperature qubit stability Archer is using the only reporte

Slide 13: Commercial Pathway
/ Commercial Pathway Jun 2019. *CQ commences building TRL* 2012. *CQ's qubit 2025-15. Basic principles of d 2016. Basic principles of quantum Prototype qubit processor devices material invented Al NPuEIng O e computing in '*CQ's qubit material in ™CQ's qubit material validated & reported Aug 2019. "

Slide 14: Commercialisation pathway applies established semiconductor business models
The commercialisation pathway involves applying well-established business models in the semiconductor industry Our strategy is to develop a qubit processor chip that can be directly sold and the intellectual property rights to the chip technology sublicensed by: 1 Building a room-temperature operati

Slide 15: Printable graphene biosensors
/ Human Health Printable graphene biosensors 15

Slide 16: Biosensor technology could disrupt a global multibillion dollar industry
Successful commercialisation of Archer’s biosensor technology could disrupt a global multibillion dollar industry $27b Forecast size of biosensor 43.5% Cash refund of annual R&D industry in 20227 spend in Australia for SMEs8 $20b 140+ Australian industry spend Life sciences companies on on R&D 20188

Slide 17: Printable biosensor could enable rapid and customised multi-disease detection
Archer’s graphene-based ink materials. Successful development of Archer’s printable biosensor could enable rapid & customised multi-disease detection 1 World-first graphene biosensor materials Archer is using the only reported graphene materials capable of stable and robust selective hierarchal chem

Slide 18: Commercial Pathway
Printers used at the ARC Graphene Hub to prepare graphene-based electrode components. / Commercial Pathway 18

Slide 19: Triple-helix business model for biotechnology innovation
Archer’s first-version biosensor platform built at the ARC Graphene Hub (Aug 2019). The commercialisation pathway involves applying the triple-helix business model+ for biotechnology innovation Our strategy is to develop printable graphene-based biosensor componentry and sublicense the associated in

Slide 20: Graphite for lithium-ion batteries
/ Reliable Energy Graphite for lithium-ion batteries 20

Slide 21: Archer's graphite could secure supply-side markets in a multibillion dollar industry
Successful commercialisation of Archer’s graphite could secure supply-side markets in a global multibillion dollar industry $130b $7k/t Forecast size of Li-ion battery Spherical graphite materials industry in 202811 entry point for Li-ion batteries12 30m Forecast number of sales of 39% Of global EV

Slide 22: Graphite could address the trade-off between cost and battery performance
Successful development of Archer’s graphite could address the trade-off between cost and battery performance 1 We High-quality graphite materials have confirmed Archer’s Campoona graphite is structurally near-perfect down to the atomic scale and is suitable for use in batteries15. High-value graphit

Slide 23: Commercial Pathway
Archer affiliates preparing chemical adducts & precursors to materials’ syntheses at UNSW. / Commercial Pathway 23

Slide 24: Downstream product integration in the lithium-ion battery supply chain
Archer graphite materials used to prepare lithium-ion battery coin-cells. The commercialisation pathway involves downstream product integration in the lithium-ion battery supply chain Our strategy is to establish customer relationships that underpin the development of our substantial Campoona graphi

Slide 25: Exploring for critical minerals
/ Mineral Exploration Exploring for critical minerals 25

Slide 26: Monetisation of tenements could be vital for securing critical minerals
Successful monetisation of Archer’s tenements could be vital for securing critical minerals for global economies $60b+ $300m+ Invested by the Australian Approx. global market value of critical minerals in Australia18 Government to de-risk mineral exploration in Australia18 50+ Critical minerals list

Slide 27: Successful exploration of tenement areas could lead to significant discoveries
Archer rock sample containing copper from Purnamoota. Successful exploration of Archer’s tenement areas could lead to significant mineral discoveries 1 AArcher broad-scope portfolio of tenement interests maintains 100% ownership of 22 Exploration Licences for a diverse range of minerals, and 1 Minin

Slide 28: Key Mineral Exploration Projects
/ Key Mineral Exploration Projects We announced§ an Exploration Target for our Independent review⨎ confirmed our Albion Downs Al Ni Eyre Peninsula High Purity Alumina Project Nickel Project is prospective for nickel mineralisation, located 12km south of Kimba, South Australia: 18km NNW of Mt Keith,

Slide 29: Monetisation of globally in-demand tenements for exploration and mining
The commercialisation pathway involves the monetisation of globally in-demand tenements for exploration and mining Our strategy is to identify a pipeline of economically proven resources for the future development, production and export of critical minerals by: 1 Exploring for Mineral Deposits Manag

Slide 30: The Path Forward
/ Strategic Direction The Path Forward 30

Slide 31: Company News Flow
/ Company News Flow Over the next 12 months key aspects of our strategy to provide shareholder returns include: + Accelerating 12CQ toward commercialisation World-first componentry assembly and device testing, and engagement with quantum computing industry partners. + Patenting & developing graphene

Slide 32: Archer Materials Limited contact details
Archer Materials Limited ASX Code: AXE ACN: 123 993 233 ADELAIDE SYDNEY Ground Floor, 28 Greenhill Road Level 4, 17-19 Bridge Street Wayville SA 5034 Australia Sydney NSW 2000 Australia Phone: +61 8 8272 3288 Phone: +61 2 8091 3240 Email: hello@archerx.com.au Website: www.archerx.com.au Twitter: htt

Slide 33: Appendices: Board and Executive Management
Appendices Board and Executive Management (Slide 4) Greg English LLB, BE (Mining) Greg English is the co-founder Archer. He has been Chairman of the board since 2008 and has overseen Executive Chairman Archer’s transition from a South Australian focussed minerals exploration company to a diverse mat

Slide 34: Appendices: Board and Executive Management
Appendices Board and Executive Management (Slide 4) Mohammad Choucair PhD, FRACI FRSN GAICD Dr Mohammad Choucair was appointed Chief Executive Officer on 1st December 2017. Dr Choucair has Chief Executive Officer a strong technical background in nanotechnology, and has spent the last decade implemen

Slide 35: Appendices: TRL and CRL references
Appendices Reference to Technology Readiness Level (“TRL”) and Commercial Readiness Level (“CRL”) on Slides 13, 18, and 23. 35
Source: Internet Archive copy of archerx.com.au
More decks from Archer Materials Limited
Shareholder Meeting (November 2026)20 slides · Nov 20, 2026
15th Annual Australian Microcap Investment Conference 202619 slides · Oct 16, 2026
Investor Presentation (July 2026)32 slides · Jul 3, 2026
H1 FY2026 Earnings Presentation11 slides · Mar 4, 2026
Investor Presentation (January 2026)10 slides · Jan 29, 2026
Shareholder Meeting (November 2025)18 slides · Nov 20, 2025